跳至主要内容
临床试验/NCT04183231
NCT04183231已完成2 期

Pharmacokinetics of Advantage Anti-Caries Varnish

Advantage Silver Dental Arrest, LLC0 个研究点目标入组 16 人开始时间: 2016年11月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
16
主要终点
Observed Fluoride AUC

研究概览

简要总结

The study aim is to characterize the kinetics of iodine and fluoride following topical application of a combined PVP-I and NaF anti-dental caries varnish in healthy adults.

详细描述

The study was to characterize serum iodine and fluoride levels over 24 hours after application of a topical dental varnish in healthy adults 23 to 57 years old.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy adults 18 y and older, at least 20 teeth, not taking prescription or OTC medications.

排除标准

  • Pregnant, weighed less than 110 pounds, had oral mucositis, ulcerative lesions, sensitivity to shellfish or iodine or fluoride varnish, or had known hypothyroidism, hyperthyroidism, dermatitis herpetiformis, hypocomplementemic vasculitis, nodular thread with heart disease, multi nodular goiter, Graves disease, or autoimmune thyroiditis

研究组 & 干预措施

Anti-caries varnish

Experimental

topical dental varnish, 10% PVP-I, 2.5% NaF, topical application to teeth, 0.4 ml, single application

干预措施: Anti-caries varnish (Drug)

结局指标

主要结局

Observed Fluoride AUC

时间窗: 0, 0.5, 1, 2, 3, 4, 6, 8, 12 and 24 hours post-dose

Area under the Curve for observed fluoride in ng\*h/mL

Observed Fluoride Baseline-Corrected AUC

时间窗: 0, 0.5, 1, 2, 3, 4, 6, 8, 12 and 24 hours post-dose

Area under the Curve for observed fluoride in ng\*h/mL

Fluoride t1/2

时间窗: 0, 0.5, 1, 2, 3, 4, 6, 8, 12 and 24 hours post-dose

Terminal elimination half-life in hours for fluoride

Observed Fluoride Total Urinary Recovery

时间窗: baseline to 24 hours

Total urinary recovery in milligrams observed

Observed Iodine Tmax

时间窗: 0, 0.5, 1, 2, 3, 4, 6, 8, 12 and 24 hours post-dose

Time to maximum serum concentration of iodine in hours

Observed Iodine Cmax

时间窗: 0, 0.5, 1, 2, 3, 4, 6, 8, 12 and 24 hours post-dose

Maximum serum concentration of iodine in ng/mL

Observed Iodine Baseline-Corrected Cmax

时间窗: 0, 0.5, 1, 2, 3, 4, 6, 8, 12 and 24 hours post-dose

Maximum serum concentration of iodine in ng/mL

Observed Iodine Baseline-Corrected AUC

时间窗: 0, 0.5, 1, 2, 3, 4, 6, 8, 12 and 24 hours post-dose

Area under the Curve for observed iodine in ng\*h/mL

Observed Iodine Total Urinary Recovery

时间窗: baseline to 24 hours

Total urinary recovery in milligrams observed

Iodine t1/2

时间窗: 0, 0.5, 1, 2, 3, 4, 6, 8, 12 and 24 hours post-dose

Terminal elimination half-life of iodine in hours

Observed Fluoride Tmax

时间窗: 0, 0.5, 1, 2, 3, 4, 6, 8, 12 and 24 hours post-dose

Time to maximum serum concentration in hours

Observed Fluoride Cmax

时间窗: 0, 0.5, 1, 2, 3, 4, 6, 8, 12 and 24 hours post-dose

Maximum serum concentration of fluoride in ng/mL

Observed Fluoride Baseline-Corrected Cmax

时间窗: 0, 0.5, 1, 2, 3, 4, 6, 8, 12 and 24 hours post-dose

Maximum serum concentration of iodine in ng/mL

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

相似试验